These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 6451692)

  • 1. Treatment complications of rheumatoid arthritis with gold, hydroxychloroquine, D-penicillamine, and levamisole.
    Husain Z; Runge LA
    J Rheumatol; 1980; 7(6):825-30. PubMed ID: 6451692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chlorbutin, azathioprine, D-penicillamine, and levamisole (Decaris) in the treatment of rheumatoid arthritis patients. I. Comparative analysis of side effects].
    Krel' AA; Kanevskaia MZ; Rashchupkina ZP; Bolotin EV; Chichasova NV
    Ter Arkh; 1981; 53(7):86-96. PubMed ID: 6457409
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk/benefit analysis of hydroxychloroquine sulfate treatment in rheumatoid arthritis.
    Runge LA
    Am J Med; 1983 Jul; 75(1A):52-6. PubMed ID: 6869411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levamisole - a possible alternative to gold and penicillamine in the longterm treatment of rheumatoid arthritis?
    Capell HA; Hunter JA; Rennie JA; Murdoch RM
    J Rheumatol; 1981; 8(5):730-40. PubMed ID: 7310774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis.
    Singh G; Fries JF; Williams CA; Zatarain E; Spitz P; Bloch DA
    J Rheumatol; 1991 Feb; 18(2):188-94. PubMed ID: 1673721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity of longterm low dose D-penicillamine therapy in rheumatoid arthritis. Cooperative Systematic Studies of Rheumatic Disease Group.
    J Rheumatol; 1987 Feb; 14(1):67-73. PubMed ID: 2952797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between D-penicillamine--induced proteinuria and prior gold nephropathy.
    Billingsley LM; Stevens MB
    Johns Hopkins Med J; 1981 Feb; 148(2):64-7. PubMed ID: 7206401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Side effects in the treatment of rheumatoid arthritis with levamisole (Decaris)].
    Petersen J; Halberg P; Hansen TM
    Ugeskr Laeger; 1979 Jul; 141(31):2123-5. PubMed ID: 158245
    [No Abstract]   [Full Text] [Related]  

  • 9. Adverse reactions to the principal drugs used in rheumatoid arthritis--a review.
    Franchimont P; Heynen G; Hauwaert CH
    J Rheumatol Suppl; 1978; 4():85-92. PubMed ID: 282449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DR antigens and proteinuria induced by aurothioglucose and D-penicillamine in patients with rheumatoid arthritis.
    Speerstra F; Reekers P; van de Putte LB; Vandenbroucke JP; Rasker JJ; de Rooij DJ
    J Rheumatol; 1983 Dec; 10(6):948-53. PubMed ID: 6420562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheumatoid arthritis: a pharmacologic overview.
    Pinals RS
    Am Fam Physician; 1988 Mar; 37(3):145-52. PubMed ID: 2894754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levamisole in rheumatoid arthritis: a comparison with D-penicillamine.
    Mowat AG; Mowat AM
    J Rheumatol; 1981; 8(4):575-80. PubMed ID: 7299760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long term treatment of rheumatoid arthritis. Experiences with D-penicillamine in comparison with gold and immunosuppressive drugs (author's transl)].
    Warnatz H; Scheiffarth F; Gutmann W
    Med Klin; 1975 Sep; 70(38):1509-15. PubMed ID: 810648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penicillamine compared to previous chrysotherapy in rheumatoid arthritis.
    Stein HB; Ruedy J; Atkins CJ; Offer RC
    J Rheumatol; 1983 Apr; 10(2):319-22. PubMed ID: 6864688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Retrospective study of adverse events in patients with rheumatoid arthritis treated with second-line drugs].
    Jiang L; Zhao N; Ni L
    Zhonghua Liu Xing Bing Xue Za Zhi; 2002 Jun; 23(3):213-7. PubMed ID: 12411093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once weekly administration of levamisole in rheumatoid arthritis.
    Fostiropoulos GA; Zissis NP; Marketos G
    Clin Invest Med; 1982; 5(4):255-8. PubMed ID: 6218948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Complications of D-penicillamine treatment of rheumatoid poly-arthritis].
    Camus JP; Crouzet J; Prier A; Leca AP
    Therapie; 1976; 31(3):385-97. PubMed ID: 136767
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of previous gold toxicity on subsequent development of penicillamine toxicity.
    Smith PJ; Swinburn WR; Swinson DR; Stewart IM
    Br Med J (Clin Res Ed); 1982 Aug 28-Sep 4; 285(6342):595-6. PubMed ID: 6218857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Goldsalts, levamisole and D-penicillamine as first choice slow-acting antirheumatic drugs in rheumatoid arthritis--a long-term follow-up study.
    Veys EM; Mielants H; Verbruggen G
    Clin Exp Rheumatol; 1987; 5(2):111-6. PubMed ID: 3608266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Penicillamine: its use in rheumatoid arthritis].
    Colombo B; Gerloni V
    Recenti Prog Med; 1979 Feb; 66(2):136-87. PubMed ID: 155862
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.